Subsequent inactivation of Kras by halting doxycycline administration in these tumor-bearing mice exhibiting signs of sickness, weight loss, and a deteriorating clinical condition ultimately returned the mice to a good health condition. The gene discussed is KRAS; the disease is neoplasm.